Casadei-Gardini, Andrea http://orcid.org/0000-0001-6289-7202
Rimassa, Lorenza
Rimini, Margherita
Yoo, Changhoon
Ryoo, Baek-Yeol
Lonardi, Sara
Masi, Gianluca
Kim, Hyung-Don
Vivaldi, Caterina
Ryu, Min-Hee
Rizzato, Mario Domenico
Salani, Francesca
Bang, Yeonghak
Pellino, Antonio
Catanese, Silvia
Burgio, Valentina
Cascinu, Stefano
Cucchetti, Alessandro
Article History
Received: 11 February 2021
Accepted: 16 March 2021
First Online: 20 March 2021
Declarations
:
: A.C.G. reports receiving consulting fees from AstraZeneca, Bayer, Eisai, MSD, Ipsen, IQVIA, lectures fees from Eisai, Ipsen, Merck Serono, Roche. L.R. reports receiving consulting fees from Amgen, ArQule, AstraZeneca, Basilea, Bayer, BMS, Celgene, Eisai, Exelixis, Genenta, Hengrui, Incyte, Ipsen, IQVIA, Lilly, MSD, Nerviano Medical Sciences, Roche, Sanofi; lectures fees from AbbVie, Amgen, Eisai, Gilead, Incyte, Ipsen, Lilly, Merck Serono, Roche, Sanofi; travel expenses from Ipsen; and institutional research funding from Agios, ARMO BioSciences, AstraZeneca, BeiGene, Eisai, Exelixis, Fibrogen, Incyte, Ipsen, Lilly, MSD, Nerviano Medical Sciences, Roche, Zymeworks. C.Y reports honoraria from BMS, MSD, Bayer, Eisai, Ipsen, AstraZeneca, and Servier; Research grants from Bayer, Ono, AstraZeneca and Servier.